Brain Cancer & Referring To The P1D1 Gene

By Rob Sutter


When it comes to brain cancer in general, I'd like to think that there is a lot that can be said about the P1D1 gene. Keep in mind that its function in the body is focused on the both regulating insulin and providing mitochondrial functionality to the body. It's not like there haven't been studies focusing on it in the past but these were more along the lines of obesity and diabetes, which are vital conditions in their own right. However, how much can the P1D1 gene tie into this type of cancer?

It's not hard to see why this gene could potentially become linked to brain cancer, as you look at the various stories on the matter. Therapies have been constructed in order to help those with tumors and it seems like each of them have been able to possess certain levels of success. In fact, said therapies are ones which organizations like Voices against Brain Cancer can bring to your attention. With that said, what makes the P1D1 so integral when it comes to helping those with cancer?

There was a report posted on Business Wire and it spoke, in detail, about the level of messenger RNA that can be found in the gene referred to as P1D1. For those who do not know, this can play greatly in terms of two conditions in particular: medulloblastomas and gliomas. P1D1 is needed in order to inhibit the growth of cells in said conditions, which speaks volumes about their functionality. With a study set in place, what can be said about this gene in relation to cancer in general?

When it comes to the therapy and its accompanying results, it probably goes without saying that higher levels of P1D1 mRNA can actually play into the survival rates of patients at large. Keep in mind that, when seen in great amounts, P1D1 can actually work well to kill tumor cells and stop the level of proliferation that would typically occur with these cells. The article mentioned how the study examined adults, seeing as how their survival rates have gone up tremendously. To say the least, this particular gene calls for attention.

It seems as though these therapies possess great potential, meaning that results are more than worth the attention they can bring. This is especially true when considering the detrimental nature that this condition has entailed. It goes without saying that many individuals have been impacted by it, so it also goes without saying that surgery on its own may not create the greatest long-term results. This may be case where focusing on the P1D1 gene is a strong idea.




About the Author:



No comments: